Breaking News Instant updates and real-time market news.

TSLA

Tesla

$288.92

-11.81 (-3.93%)

08:04
10/25/18
10/25
08:04
10/25/18
08:04

Tesla price target raised to $325 from $315 at RBC Capital

RBC Capital analyst Joseph Spak raised his price target on Tesla to $325 after its "strong" Q3 results were helped by the Model 3 heavy sales mix. The analyst notes that these results may be "sustainable" in the near term while the company figures out profitability for its lower-end Model 3 and anticipates some positive momentum for the stock but also keeps his Sector Perform rating on Tesla's "fair valuation".

  • 29

    Oct

  • 13

    Dec

TSLA Tesla
$288.92

-11.81 (-3.93%)

10/25/18
LEHM
10/25/18
NO CHANGE
Target $210
LEHM
Underweight
Tesla results put 'extreme bear case to rest,' says Barclays
The cash generation and stronger margin performance in Tesla's Q3 "put the 'extreme' bear case to rest for a while but doesn't dispel the valuation debate," Barclays analyst Brian Johnson tells investors in a post-earnings research note titled "Extreme bear fears of distress prove misplaced." Further, the analyst feels that while Tesla's profit and improvement "was impressive," it comes after a "rich Model 3 mix" that's unlikely to be replicated. Tesla will soon be facing flat sequential revenue growth and by year-end 2019, slower year-over-year growth, says Johnson. The analyst keeps an Underweight rating on Tesla, but admits he does not have "near-term hopes" of seeing his $210 price target. However, he believes Tesla's "stabilizing growth" makes his "long-term valuation more realistic."
10/25/18
NEED
10/25/18
NO CHANGE
NEED
Underperform
Concerns over Tesla margins remains after profitable Q3, says Needham
Needham analyst Rajvindra Gill kept his Underperform rating on Tesla, saying that while the company posted its first quarterly profit and positive free cash flow in over two years in Q3 thanks to higher-margin Model 3 sales, he remains concerned over margin in the first half of 2019. The analyst cites an "unfavorable mix shift of Model 3s, decline in ZEV sales, service margins stay in -35-40% and pricing pressure on Model S/X". Gill also questions the speed and profitability of Tesla's production of a $45K car, "not to mention the $35K version", in order to match its backlog of orders.
10/25/18
NOMU
10/25/18
NO CHANGE
Target $300
NOMU
Neutral
Tesla may now be 'sustainably self-funded entity,' says Nomura Instinet
Tesla "flexed its model leverage muscles" in Q3, exhibiting a "dramatic swing from negative to positive on a number of key metrics," Nomura Instinet analyst Romit Shah tells investors in a post-earnings research note titled "From Negative to Positive." These included Model 3 gross margins, earnings, and most importantly, cash flow, says Shah. He points out that Tesla reiterated its confidence in continued profitability and free cash flow positivity in every period going forward. In other words, Q3 may mark the quarter in which Tesla became a "sustainably self-funded entity," contends Shah. He keeps a Neutral rating on the shares with a $300 price target. The stock in premarket trading is up 11%, or $30.65, to $319.15.
10/25/18
MSCO
10/25/18
NO CHANGE
Target $291
MSCO
Equal Weight
Tesla reported 'strongest quarter in its history,' says Morgan Stanley
Morgan Stanley analyst Adam Jonas said Tesla's Q3 was "its strongest quarter in history by virtually every metric," adding that its Q4 guidance implies slightly lower gross margins and positive free cash flow. The quality of cash flow was stronger than expected, added Jonas, who believes one of the most important debates for Tesla is when they can become self-sufficient on free cash flow. While he raised his estimates "materially" following the much stronger than expected Q3 results and free cash flow, Jonas continues to question the sustainability of these results and keeps an Equal Weight rating on Tesla shares with an unchanged price target of $291.

TODAY'S FREE FLY STORIES

PPC

Pilgrim's Pride

$25.55

0.06 (0.24%)

, SAFM

Sanderson Farms

$133.69

-0.32 (-0.24%)

14:28
06/25/19
06/25
14:28
06/25/19
14:28
Periodicals
DOJ opens criminal probe into poultry price fixing allegations, Bloomberg says »

The Justice Department…

PPC

Pilgrim's Pride

$25.55

0.06 (0.24%)

SAFM

Sanderson Farms

$133.69

-0.32 (-0.24%)

TSN

Tyson Foods

$82.58

1.74 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AA

Alcoa

$22.67

0.46 (2.07%)

14:25
06/25/19
06/25
14:25
06/25/19
14:25
Options
Alcoa call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

VNE

Veoneer

$17.63

0.31 (1.79%)

14:23
06/25/19
06/25
14:23
06/25/19
14:23
Conference/Events
Veoneer management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

UBS

UBS

$11.61

-0.065 (-0.56%)

, FB

Facebook

$189.48

-3.08 (-1.60%)

14:20
06/25/19
06/25
14:20
06/25/19
14:20
Periodicals
UBS CEO welcomes cryptocurrency innovation but still wary, Reuters says »

UBS (UBS) CEO Sergio…

UBS

UBS

$11.61

-0.065 (-0.56%)

FB

Facebook

$189.48

-3.08 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
06/25/19
06/25
14:17
06/25/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
06/25/19
06/25
14:16
06/25/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$66.96

-0.48 (-0.71%)

14:15
06/25/19
06/25
14:15
06/25/19
14:15
Options
Best Buy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAR

Par Technology

$28.13

0.09 (0.32%)

14:11
06/25/19
06/25
14:11
06/25/19
14:11
Initiation
Par Technology initiated at Sidoti »

Par Technology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.96

-1.68 (-0.57%)

14:09
06/25/19
06/25
14:09
06/25/19
14:09
Periodicals
Presidents Trump, Xi to meet Saturday in Japan, Reuters says »

The goal of a meeting…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.96

-1.68 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$14.69

0.24 (1.66%)

14:05
06/25/19
06/25
14:05
06/25/19
14:05
Options
US Steel call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
06/25/19
06/25
14:05
06/25/19
14:05
General news
More from Powell: the inflation undershoot may be more persistent and hoped »

More from Powell: the…

AMZN

Amazon.com

$1,890.62

-22.81 (-1.19%)

14:04
06/25/19
06/25
14:04
06/25/19
14:04
Hot Stocks
Amazon teams with Seattle Public Schools to bring computer science and robotics »

Amazon and Seattle Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

AGN

Allergan

$164.23

34.58 (26.67%)

, ABBV

AbbVie

$66.38

-12.035 (-15.35%)

14:03
06/25/19
06/25
14:03
06/25/19
14:03
Downgrade
Allergan, AbbVie rating change at Raymond James »

Allergan downgraded to…

AGN

Allergan

$164.23

34.58 (26.67%)

ABBV

AbbVie

$66.38

-12.035 (-15.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

MMP

Magellan Midstream

$62.18

0.06 (0.10%)

13:57
06/25/19
06/25
13:57
06/25/19
13:57
Periodicals
Magellan seeking sale of stake in Longhorn crude pipeline, Reuters says »

Magellan Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/25/19
06/25
13:55
06/25/19
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

MMP

Magellan Midstream

$62.21

0.09 (0.14%)

13:48
06/25/19
06/25
13:48
06/25/19
13:48
Periodicals
Magellan Midstream seeks to sell Longhorn pipeline stake, Reuters says »

Magellan Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$8.32

-0.15 (-1.77%)

13:45
06/25/19
06/25
13:45
06/25/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

13:45
06/25/19
06/25
13:45
06/25/19
13:45
General news
Treasury Action: yields are flat to lower after Fed comments »

Treasury Action: yields…

GIS

General Mills

$53.74

0.08 (0.15%)

, PAYX

Paychex

$85.15

-1.02 (-1.18%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$53.74

0.08 (0.15%)

PAYX

Paychex

$85.15

-1.02 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

FDX

FedEx

$156.37

-4.51 (-2.80%)

, MU

Micron

$33.30

0.12 (0.36%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting after market close »

Notable companies…

FDX

FedEx

$156.37

-4.51 (-2.80%)

MU

Micron

$33.30

0.12 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

13:37
06/25/19
06/25
13:37
06/25/19
13:37
Periodicals
Presidents Trump, Xi to meet Saturday in Japan, Reuters says »

Presidents Trump and Xi…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.05

-0.93 (-2.33%)

13:35
06/25/19
06/25
13:35
06/25/19
13:35
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary at Stifel »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.